Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis

por Pineda, M A, Al-Riyami, L, Harnett, W, Harnett, M M
Publicado 2014

The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma

por Coltherd, J. C., Rodgers, D. T., Lawrie, R. E., Al-Riyami, L., Suckling, C. J., Harnett, W., Harnett, M. M.
Publicado 2016